MAY/JUNE

Vol 9, No 3 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours. CME is presented by an unrestricted educational grant from Bristol-Myers Squibb Oncology Division.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• understand the role of the sentinel node technique in modern oncologic surgery,

• discuss the most significant trials of sentinel node surgery,

• prescribe appropriate cytokines for older patients who will receive chemotherapy for non-Hodgkin’s lymphoma,

• recognize hypopituitarism in childhood and discuss its causes,

• manage patients with acromegaly, and

• counsel patients on the benefits and risks of complementary therapy for cancer.

This program was planned in accordance with ACCME Essentials.

Release Date: May1, 2002
Expiration Date: May 1, 2003

1. A patient having which one of the following characteristics of a newly diagnosed breast cancer would be the best candidate for a lymph node mapping procedure?

a. infiltrating tumor 1.5 cm in diameter
b. infiltrating tumor larger than 5 cm
c. palpable axillary nodes
d. minimal ductal carcinoma in situ

2. During which cycles of CHOP chemotherapy for treating non-Hodgkin’s lymphoma does neutropenia-related mortality tend to occur most often?

a. middle
b. early
c. any
d. late

3. Which dietary supplement may cause drowsiness, dizziness, and intoxication?

a. Icelandic moss
b. green tea
c. kava kava
d. ginseng